UBS AM’s Achillion Pharmaceuticals ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-714,432
Closed -$4.31M 2567
2019
Q4
$4.31M Buy
714,432
+532,918
+294% +$3.08M ﹤0.01% 1254
2019
Q3
$653K Buy
181,514
+8,681
+5% +$33.5K ﹤0.01% 2157
2019
Q2
$463K Buy
172,833
+84,513
+96% +$250K ﹤0.01% 2247
2019
Q1
$261K Buy
88,320
+5,000
+6% +$12.3K ﹤0.01% 2366
2018
Q4
$132K Hold
83,320
﹤0.01% 2485
2018
Q3
$307K Hold
83,320
﹤0.01% 2275
2018
Q2
$236K Buy
83,320
+3,800
+5% +$12.9K ﹤0.01% 2408
2018
Q1
$295K Buy
79,520
+14,881
+23% +$48.7K ﹤0.01% 2219
2017
Q4
$186K Hold
64,639
﹤0.01% 2335
2017
Q3
$290K Buy
64,639
+970
+2% +$4.31K ﹤0.01% 2097
2017
Q2
$292K Buy
63,669
+10,000
+19% +$40.2K ﹤0.01% 2047
2017
Q1
$226K Buy
53,669
+24,471
+84% +$102K ﹤0.01% 2134
2016
Q4
$121K Sell
29,198
-37,800
-56% -$201K ﹤0.01% 2219
2016
Q3
$543K Hold
66,998
﹤0.01% 1935
2016
Q2
$523K Hold
66,998
﹤0.01% 1934
2016
Q1
$517K Buy
66,998
+1,039
+2% +$7.61K ﹤0.01% 1901
2015
Q4
$712K Sell
65,959
-580,200
-90% -$5.27M ﹤0.01% 1878
2015
Q3
$4.46M Sell
646,159
-9,300
-1% -$75.8K ﹤0.01% 1098
2015
Q2
$5.81M Buy
655,459
+17,000
+3% +$161K 0.01% 1022
2015
Q1
$6.29M Buy
638,459
+10,200
+2% +$127K 0.01% 1001
2014
Q4
$7.7M Buy
628,259
+149,300
+31% +$1.82M 0.01% 941
2014
Q3
$4.78M Buy
478,959
+430,000
+878% +$3.99M ﹤0.01% 1043
2014
Q2
$371K Hold
48,959
﹤0.01% 2062
2014
Q1
$161K Buy
48,959
+8,800
+22% +$30.8K ﹤0.01% 2472
2013
Q4
$133K Sell
40,159
-2,061,906
-98% -$5.98M ﹤0.01% 2472
2013
Q3
$6.35M Buy
2,102,065
+516,300
+33% +$3.54M 0.01% 927
2013
Q2
$13M Buy
+1,585,765
New +$12.1M 0.02% 693